Cell Signaling Technology

Phospho-PAR-4 (Thr163) Antibody

#2329 · $362

100
Citing papers
18.6k
Combined citations
Supplier page Find this product

Research areas

MicroRNA in disease regulation8Cell death mechanisms and regulation7PI3K/AKT/mTOR signaling in cancer6Cancer-related molecular mechanisms research6RNA modifications and cancer6Cancer Immunotherapy and Biomarkers5Epigenetics and DNA Methylation5Autophagy in Disease and Therapy5

Papers citing this product

1
Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma
Nature Genetics·2013·835 cit.·DOI
2
Microbiota-derived short-chain fatty acids promote Th1 cell IL-10 production to maintain intestinal homeostasis
Nature Communications·2018·656 cit.·DOI
3
Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer’s Disease Phenotypes
PLoS ONE·2016·573 cit.·DOI
4
PKM2 regulates the Warburg effect and promotes HMGB1 release in sepsis
Nature Communications·2014·511 cit.·DOI
5
BIM Mediates EGFR Tyrosine Kinase Inhibitor-Induced Apoptosis in Lung Cancers with Oncogenic EGFR Mutations
PLoS Medicine·2007·490 cit.·DOI
6
Single-Cell Transcriptomics Uncovers Zonation of Function in the Mesenchyme during Liver Fibrosis
Cell Reports·2019·420 cit.·DOI
7
Adipocyte lipolysis links obesity to breast cancer growth: adipocyte-derived fatty acids drive breast cancer cell proliferation and migration
Cancer & Metabolism·2017·413 cit.·DOI
8
MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition
The Journal of Experimental Medicine·2012·395 cit.·DOI
9
Chronic oral application of a periodontal pathogen results in brain inflammation, neurodegeneration and amyloid beta production in wild type mice
PLoS ONE·2018·360 cit.·DOI
10
Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial–mesenchymal transition (EMT) to mesenchymal–epithelial transition (MET) states
British Journal of Cancer·2014·355 cit.·DOI